Fluphenazine Decanoate, Fluphenazine Hydrochloride Given Orally, and Placebo in Remitted Schizophrenics: I. Relapse Rates After One Year

Arthur Rifkin; Fredric Quitkin; Charles J. Rabiner; Donald F. Klein

doi:10.1001/archpsyc.1977.01770130045004

糖心vlog

Article

闯补苍耻补谤测听1977

Fluphenazine Decanoate, Fluphenazine Hydrochloride Given Orally, and Placebo in Remitted Schizophrenics: I. Relapse Rates After One Year

Arthur Rifkin, MD; Fredric Quitkin, MD; Charles J. Rabiner, MD; et al Donald F. Klein, MD

Author Affiliations

From the Department of Psychiatry, Long Island Jewish-Hillside Medical Center, Glen Oaks, New York. Drs Rifkin and Klein are presently with the New York State Psychiatric Institute and The College of Physicians and Surgeons, Columbia University, New York. Drs Rifkin, Quitkin, and Klein are now with the New York State Psychiatric Institute, New York.

Arch Gen Psychiatry. 1977;34(1):43-47. doi:10.1001/archpsyc.1977.01770130045004

Abstract

鈥� In a sample of remitted, nonpsychotic schizophrenics, the relapse rate within one year was significantly higher for those patients taking placebo as opposed to those taking fluphenazine hydrochloride orally or fluphenazine decanoate. There were no differences in relapse rates between the two active drugs, but there were significantly more terminations due to toxicity from fluphenazine decanoate than from fluphenazine given orally, entirely due to the fact that in 35% of patients receiving fluphenazine decanoate, severe akinesia developed.

糖心vlog

Object moved to here.

糖心vlog

Fluphenazine Decanoate, Fluphenazine Hydrochloride Given Orally, and Placebo in Remitted Schizophrenics: I. Relapse Rates After One Year

Others Also Liked

Featured Articles

USPSTF Recommendation Statements

Blogs

糖心vlog

Object moved to here.

糖心vlog

Select Your Interests

Fluphenazine Decanoate, Fluphenazine Hydrochloride Given Orally, and Placebo in Remitted Schizophrenics: I. Relapse Rates After One Year

Citation

Manage citations:

Others Also Liked